Investors Research Corp Amgen Inc Transaction History

Investors Research Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $8,932 - $11,349	39 Added 278.57%	53 $13,000
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $3,142 - $3,544	14 New	14 $3,000
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $55,477 - $64,650	-250 Closed	0 $0
Q1 2019 Apr 23, 2019	BUY	$180.87 - $203.88 $45,217 - $50,970	250 New	250 $47,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

Stay updated on Investors Research Corp with notifications on news.